Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic

Marie Thérèse Labro1, Houria Abdelghaffar, Catherine Babin-Chevaye

  • 1INSERM U479, CHU Xavier Bichat, 75018, Paris, France. labro@bichat.inserm.fr

Insights

The novel ketolide ABT-773 is efficiently taken up by human polymorphonuclear neutrophils (PMNs) via an active transport system, accumulating better than HMR 3004. This uptake mechanism is shared by other macrolides and ketolides.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Immunology

Background:

  • Ketolides are a class of antibiotics with potential activity against various bacterial infections.
  • Understanding the cellular uptake mechanisms of antibiotics is crucial for optimizing their efficacy and predicting their pharmacokinetic profiles.
  • Human polymorphonuclear neutrophils (PMNs) are key immune cells involved in combating bacterial infections.

Purpose of the Study:

  • To investigate the in vitro uptake kinetics of the novel ketolide ABT-773 by human PMNs and a myelomonoblastic cell line (PLB-985).
  • To compare the uptake of ABT-773 with another compound, HMR 3004.
  • To elucidate the transport mechanism and cellular localization of ABT-773 within these cells.

Main Methods:

  • Classical velocity centrifugation was employed to study drug uptake.
  • Cellular concentration to extracellular concentration ratios (C/E) were measured over time.
  • Uptake was assessed in differentiated and non-differentiated PLB-985 cells, as well as in PMNs.
  • The effects of verapamil, H89, external pH, temperature, and other antibiotics on ABT-773 uptake were evaluated.

Main Results:

  • ABT-773 demonstrated rapid uptake by PMNs, reaching a plateau within 5 minutes and accumulating significantly better than HMR 3004.
  • Uptake was saturable and concentration-dependent, suggesting an active transport system on the PMN membrane.
  • ABT-773 was primarily located in the cytosol and was rapidly released, indicating potential reuptake mechanisms.
  • Differentiated PLB-985 cells showed similar uptake kinetics to PMNs, while non-differentiated cells accumulated less drug.

Conclusions:

  • An active transport system, common to macrolides and ketolides, is involved in ABT-773 uptake by human PMNs.
  • The cellular accumulation and release characteristics of ABT-773 suggest complex transport dynamics.
  • These findings contribute to understanding the pharmacokinetics of ketolides and their interaction with immune cells.

Related Concept Videos